vs
Amarin Corp plc（AMRN）与CITIZENS FINANCIAL SERVICES INC（CZFS）财务数据对比。点击上方公司名可切换其他公司
Amarin Corp plc的季度营收约是CITIZENS FINANCIAL SERVICES INC的1.5倍（$45.1M vs $29.6M），CITIZENS FINANCIAL SERVICES INC净利率更高（35.4% vs -23.3%，领先58.7%），CITIZENS FINANCIAL SERVICES INC同比增速更快（13.0% vs 7.0%），过去两年CITIZENS FINANCIAL SERVICES INC的营收复合增速更高（6.9% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
公民金融集团是一家美国银行控股公司，总部位于罗得岛州普罗维登斯。集团旗下拥有公民银行（Citizens Bank, N.A.），业务覆盖美国康涅狄格、特拉华、佛罗里达等十余个州及华盛顿哥伦比亚特区。
AMRN vs CZFS — 直观对比
营收规模更大
AMRN
是对方的1.5倍
$29.6M
营收增速更快
CZFS
高出6.0%
7.0%
净利率更高
CZFS
高出58.7%
-23.3%
两年增速更快
CZFS
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $29.6M |
| 净利润 | $-10.5M | $10.5M |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 44.2% |
| 净利率 | -23.3% | 35.4% |
| 营收同比 | 7.0% | 13.0% |
| 净利润同比 | 33.0% | 31.3% |
| 每股收益（稀释后） | — | $2.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNCZFS
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $29.6M | ||
| Q3 25 | $49.7M | $29.0M | ||
| Q2 25 | $72.7M | $27.3M | ||
| Q1 25 | $42.0M | $26.4M | ||
| Q4 24 | $62.3M | $26.2M | ||
| Q3 24 | $42.3M | $25.1M | ||
| Q2 24 | $67.5M | $24.6M |
净利润AMRNCZFS
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | $10.5M | ||
| Q3 25 | $-7.7M | $10.0M | ||
| Q2 25 | $-14.1M | $8.5M | ||
| Q1 25 | $-15.7M | $7.6M | ||
| Q4 24 | $-48.6M | $8.0M | ||
| Q3 24 | $-25.1M | $7.5M | ||
| Q2 24 | $1.5M | $5.3M |
毛利率AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNCZFS
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 44.2% | ||
| Q3 25 | -22.4% | 42.6% | ||
| Q2 25 | -22.0% | 38.1% | ||
| Q1 25 | -39.9% | 35.5% | ||
| Q4 24 | -84.3% | 37.2% | ||
| Q3 24 | -59.5% | 36.9% | ||
| Q2 24 | -0.8% | 25.9% |
净利率AMRNCZFS
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | 35.4% | ||
| Q3 25 | -15.6% | 34.5% | ||
| Q2 25 | -19.4% | 31.0% | ||
| Q1 25 | -37.4% | 28.8% | ||
| Q4 24 | -78.0% | 30.5% | ||
| Q3 24 | -59.4% | 30.0% | ||
| Q2 24 | 2.3% | 21.4% |
每股收益（稀释后）AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $2.17 | ||
| Q3 25 | $-0.02 | $2.09 | ||
| Q2 25 | $-0.03 | $1.76 | ||
| Q1 25 | $-0.04 | $1.60 | ||
| Q4 24 | $-0.12 | $1.64 | ||
| Q3 24 | $-0.06 | $1.57 | ||
| Q2 24 | $0.00 | $1.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $34.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $338.1M |
| 总资产 | $645.8M | $3.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNCZFS
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $34.3M | ||
| Q3 25 | $286.6M | $31.1M | ||
| Q2 25 | $298.7M | $49.5M | ||
| Q1 25 | $281.8M | $36.8M | ||
| Q4 24 | $294.2M | $42.2M | ||
| Q3 24 | $305.7M | $36.8M | ||
| Q2 24 | $306.7M | $38.4M |
股东权益AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $338.1M | ||
| Q3 25 | $458.9M | $327.7M | ||
| Q2 25 | $464.9M | $313.7M | ||
| Q1 25 | $473.7M | $308.3M | ||
| Q4 24 | $486.2M | $299.7M | ||
| Q3 24 | $531.4M | $298.7M | ||
| Q2 24 | $551.9M | $286.5M |
总资产AMRNCZFS
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $3.1B | ||
| Q3 25 | $659.8M | $3.1B | ||
| Q2 25 | $670.1M | $3.0B | ||
| Q1 25 | $655.7M | $3.0B | ||
| Q4 24 | $685.3M | $3.0B | ||
| Q3 24 | $750.6M | $3.0B | ||
| Q2 24 | $799.9M | $2.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $36.5M |
| 自由现金流经营现金流 - 资本支出 | — | $35.2M |
| 自由现金流率自由现金流/营收 | — | 119.0% |
| 资本支出强度资本支出/营收 | — | 4.4% |
| 现金转化率经营现金流/净利润 | — | 3.49× |
| 过去12个月自由现金流最近4个季度 | — | $53.8M |
8季度趋势，按日历期对齐
经营现金流AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $36.5M | ||
| Q3 25 | $-12.7M | $2.9M | ||
| Q2 25 | $16.6M | $6.0M | ||
| Q1 25 | $-12.5M | $10.9M | ||
| Q4 24 | $-13.3M | $33.2M | ||
| Q3 24 | $-2.4M | $6.2M | ||
| Q2 24 | $-2.7M | $3.0M |
自由现金流AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | — | $35.2M | ||
| Q3 25 | — | $2.7M | ||
| Q2 25 | — | $5.5M | ||
| Q1 25 | — | $10.4M | ||
| Q4 24 | — | $31.9M | ||
| Q3 24 | — | $5.6M | ||
| Q2 24 | — | $2.9M |
自由现金流率AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | — | 119.0% | ||
| Q3 25 | — | 9.4% | ||
| Q2 25 | — | 20.1% | ||
| Q1 25 | — | 39.2% | ||
| Q4 24 | — | 121.6% | ||
| Q3 24 | — | 22.3% | ||
| Q2 24 | — | 11.8% |
资本支出强度AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | — | 4.4% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.2% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 0.5% |
现金转化率AMRNCZFS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.49× | ||
| Q3 25 | — | 0.29× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 4.16× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | -1.81× | 0.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
CZFS
暂无分部数据
